nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—Methylation Pathways—COMT—Parkinson's disease	0.0366	0.0871	CbGpPWpGaD
Bendroflumethiazide—CA1—nerve—Parkinson's disease	0.0352	0.0607	CbGeAlD
Bendroflumethiazide—KCNMA1—hindbrain—Parkinson's disease	0.0347	0.0599	CbGeAlD
Bendroflumethiazide—TPMT—Methylation—COMT—Parkinson's disease	0.0336	0.08	CbGpPWpGaD
Bendroflumethiazide—CA4—nerve—Parkinson's disease	0.0275	0.0475	CbGeAlD
Bendroflumethiazide—KCNMA1—Potassium Channels—HCN3—Parkinson's disease	0.0213	0.0508	CbGpPWpGaD
Bendroflumethiazide—CA4—hindbrain—Parkinson's disease	0.0206	0.0355	CbGeAlD
Bendroflumethiazide—KCNMA1—brainstem—Parkinson's disease	0.0199	0.0343	CbGeAlD
Bendroflumethiazide—KCNMA1—forebrain—Parkinson's disease	0.0192	0.0331	CbGeAlD
Bendroflumethiazide—CA2—hindbrain—Parkinson's disease	0.0171	0.0295	CbGeAlD
Bendroflumethiazide—KCNMA1—cardiovascular system—Parkinson's disease	0.0162	0.028	CbGeAlD
Bendroflumethiazide—TPMT—medulla oblongata—Parkinson's disease	0.0149	0.0257	CbGeAlD
Bendroflumethiazide—CA1—forebrain—Parkinson's disease	0.0146	0.0252	CbGeAlD
Bendroflumethiazide—KCNMA1—Potassium Channels—KCNJ4—Parkinson's disease	0.0138	0.0328	CbGpPWpGaD
Bendroflumethiazide—TPMT—midbrain—Parkinson's disease	0.0136	0.0235	CbGeAlD
Bendroflumethiazide—TPMT—spinal cord—Parkinson's disease	0.0133	0.0229	CbGeAlD
Bendroflumethiazide—KCNMA1—midbrain—Parkinson's disease	0.0127	0.0219	CbGeAlD
Bendroflumethiazide—CA1—cardiovascular system—Parkinson's disease	0.0123	0.0213	CbGeAlD
Bendroflumethiazide—TPMT—head—Parkinson's disease	0.0118	0.0204	CbGeAlD
Bendroflumethiazide—CA4—brainstem—Parkinson's disease	0.0118	0.0204	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTA4—Parkinson's disease	0.0118	0.028	CbGpPWpGaD
Bendroflumethiazide—CA4—forebrain—Parkinson's disease	0.0114	0.0197	CbGeAlD
Bendroflumethiazide—TPMT—nervous system—Parkinson's disease	0.0112	0.0193	CbGeAlD
Bendroflumethiazide—KCNMA1—head—Parkinson's disease	0.011	0.019	CbGeAlD
Bendroflumethiazide—TPMT—central nervous system—Parkinson's disease	0.0108	0.0186	CbGeAlD
Bendroflumethiazide—CA2—embryo—Parkinson's disease	0.0107	0.0184	CbGeAlD
Bendroflumethiazide—TPMT—cerebellum—Parkinson's disease	0.0105	0.0182	CbGeAlD
Bendroflumethiazide—KCNMA1—nervous system—Parkinson's disease	0.0104	0.018	CbGeAlD
Bendroflumethiazide—KCNMA1—central nervous system—Parkinson's disease	0.01	0.0173	CbGeAlD
Bendroflumethiazide—KCNMA1—cerebellum—Parkinson's disease	0.00981	0.0169	CbGeAlD
Bendroflumethiazide—CA2—brainstem—Parkinson's disease	0.0098	0.0169	CbGeAlD
Bendroflumethiazide—CA4—cardiovascular system—Parkinson's disease	0.00964	0.0166	CbGeAlD
Bendroflumethiazide—CA2—forebrain—Parkinson's disease	0.00946	0.0163	CbGeAlD
Bendroflumethiazide—CA1—spinal cord—Parkinson's disease	0.0094	0.0162	CbGeAlD
Bendroflumethiazide—KCNMA1—Neuronal System—HCN3—Parkinson's disease	0.00932	0.0222	CbGpPWpGaD
Bendroflumethiazide—TPMT—brain—Parkinson's disease	0.00857	0.0148	CbGeAlD
Bendroflumethiazide—CA1—head—Parkinson's disease	0.00836	0.0144	CbGeAlD
Bendroflumethiazide—CA4—medulla oblongata—Parkinson's disease	0.00824	0.0142	CbGeAlD
Bendroflumethiazide—CA2—cardiovascular system—Parkinson's disease	0.008	0.0138	CbGeAlD
Bendroflumethiazide—KCNMA1—brain—Parkinson's disease	0.00797	0.0137	CbGeAlD
Bendroflumethiazide—CA1—nervous system—Parkinson's disease	0.00792	0.0137	CbGeAlD
Bendroflumethiazide—CA1—central nervous system—Parkinson's disease	0.00763	0.0131	CbGeAlD
Bendroflumethiazide—CA4—midbrain—Parkinson's disease	0.00753	0.013	CbGeAlD
Bendroflumethiazide—CA4—spinal cord—Parkinson's disease	0.00735	0.0127	CbGeAlD
Bendroflumethiazide—TPMT—Biological oxidations—GSTA4—Parkinson's disease	0.00687	0.0164	CbGpPWpGaD
Bendroflumethiazide—CA2—medulla oblongata—Parkinson's disease	0.00683	0.0118	CbGeAlD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00678	0.0161	CbGpPWpGaD
Bendroflumethiazide—CA4—head—Parkinson's disease	0.00653	0.0113	CbGeAlD
Bendroflumethiazide—CA2—midbrain—Parkinson's disease	0.00624	0.0108	CbGeAlD
Bendroflumethiazide—CA4—nervous system—Parkinson's disease	0.00619	0.0107	CbGeAlD
Bendroflumethiazide—TPMT—Biological oxidations—MAOB—Parkinson's disease	0.00613	0.0146	CbGpPWpGaD
Bendroflumethiazide—CA2—spinal cord—Parkinson's disease	0.00609	0.0105	CbGeAlD
Bendroflumethiazide—CA1—brain—Parkinson's disease	0.00605	0.0104	CbGeAlD
Bendroflumethiazide—KCNMA1—Neuronal System—KCNJ4—Parkinson's disease	0.006	0.0143	CbGpPWpGaD
Bendroflumethiazide—CA4—central nervous system—Parkinson's disease	0.00596	0.0103	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—COMT—Parkinson's disease	0.0059	0.0141	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTP1—Parkinson's disease	0.00587	0.014	CbGpPWpGaD
Bendroflumethiazide—CA4—cerebellum—Parkinson's disease	0.00583	0.01	CbGeAlD
Bendroflumethiazide—CA2—head—Parkinson's disease	0.00542	0.00933	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTM1—Parkinson's disease	0.0054	0.0129	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00529	0.0126	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—DLG1—Parkinson's disease	0.00518	0.0123	CbGpPWpGaD
Bendroflumethiazide—CA2—nervous system—Parkinson's disease	0.00513	0.00885	CbGeAlD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DDC—Parkinson's disease	0.00511	0.0122	CbGpPWpGaD
Bendroflumethiazide—CA2—central nervous system—Parkinson's disease	0.00494	0.00852	CbGeAlD
Bendroflumethiazide—CA2—cerebellum—Parkinson's disease	0.00483	0.00833	CbGeAlD
Bendroflumethiazide—CA4—brain—Parkinson's disease	0.00473	0.00816	CbGeAlD
Bendroflumethiazide—TPMT—Biological oxidations—CYP2D6—Parkinson's disease	0.00455	0.0108	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00449	0.0107	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—DOCK3—Parkinson's disease	0.00439	0.0104	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MERTK—Parkinson's disease	0.00439	0.0104	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—CYP2E1—Parkinson's disease	0.00417	0.00992	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00411	0.00978	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—GRIK1—Parkinson's disease	0.00406	0.00966	CbGpPWpGaD
Bendroflumethiazide—CA2—brain—Parkinson's disease	0.00392	0.00676	CbGeAlD
Bendroflumethiazide—KCNMA1—Hemostasis—DGKQ—Parkinson's disease	0.00391	0.00931	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00381	0.00908	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00373	0.00888	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.00372	0.00886	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00357	0.0085	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00357	0.0085	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—COMT—Parkinson's disease	0.00345	0.00822	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—GRIK2—Parkinson's disease	0.00345	0.00821	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTP1—Parkinson's disease	0.00344	0.00818	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00343	0.00817	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—MAOA—Parkinson's disease	0.00343	0.00816	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—COMT—Parkinson's disease	0.0034	0.00811	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00339	0.00807	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—SLC18A2—Parkinson's disease	0.00334	0.00795	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00319	0.00761	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTM1—Parkinson's disease	0.00316	0.00752	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00311	0.00741	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00309	0.00737	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TH—Parkinson's disease	0.00285	0.00678	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—DRD2—Parkinson's disease	0.0028	0.00666	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—HTR7—Parkinson's disease	0.0028	0.00666	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—CHRNA4—Parkinson's disease	0.00264	0.00629	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAG—Parkinson's disease	0.00252	0.006	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00244	0.00582	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HSPA8—Parkinson's disease	0.00242	0.00577	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—DLG4—Parkinson's disease	0.00227	0.00541	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MCCC1—Parkinson's disease	0.00224	0.00533	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ND3—Parkinson's disease	0.00224	0.00533	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—GRIN2B—Parkinson's disease	0.00222	0.00529	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—SLC6A3—Parkinson's disease	0.00219	0.00522	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TALDO1—Parkinson's disease	0.0021	0.00501	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—OMD—Parkinson's disease	0.0021	0.00501	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NDUFB11—Parkinson's disease	0.00199	0.00475	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GCH1—Parkinson's disease	0.0019	0.00453	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00189	0.00451	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—COMT—Parkinson's disease	0.00186	0.00443	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MAOA—Parkinson's disease	0.00185	0.0044	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00174	0.00415	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GBA—Parkinson's disease	0.0017	0.00404	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—FBP1—Parkinson's disease	0.0017	0.00404	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—DBH—Parkinson's disease	0.0017	0.00404	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ND3—Parkinson's disease	0.00162	0.00385	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MCCC1—Parkinson's disease	0.00162	0.00385	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FGB—Parkinson's disease	0.00159	0.00378	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MCCC1—Parkinson's disease	0.00155	0.00369	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ND3—Parkinson's disease	0.00155	0.00369	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TALDO1—Parkinson's disease	0.00152	0.00362	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—OMD—Parkinson's disease	0.00152	0.00362	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MCCC1—Parkinson's disease	0.00149	0.00354	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ND3—Parkinson's disease	0.00149	0.00354	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—OMD—Parkinson's disease	0.00146	0.00347	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TALDO1—Parkinson's disease	0.00146	0.00347	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NDUFB11—Parkinson's disease	0.00144	0.00343	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TALDO1—Parkinson's disease	0.0014	0.00333	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—OMD—Parkinson's disease	0.0014	0.00333	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NDUFB11—Parkinson's disease	0.00138	0.00329	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GCH1—Parkinson's disease	0.00138	0.00328	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NDUFB11—Parkinson's disease	0.00133	0.00316	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GCH1—Parkinson's disease	0.00132	0.00314	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GCH1—Parkinson's disease	0.00126	0.00301	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—DDC—Parkinson's disease	0.00124	0.00297	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00124	0.00296	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GBA—Parkinson's disease	0.00123	0.00292	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FBP1—Parkinson's disease	0.00123	0.00292	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—DBH—Parkinson's disease	0.00123	0.00292	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00119	0.00284	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SOD1—Parkinson's disease	0.00118	0.00281	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—DBH—Parkinson's disease	0.00118	0.0028	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FBP1—Parkinson's disease	0.00118	0.0028	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GBA—Parkinson's disease	0.00118	0.0028	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTA4—Parkinson's disease	0.00118	0.0028	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—DBH—Parkinson's disease	0.00113	0.00268	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GBA—Parkinson's disease	0.00113	0.00268	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—FBP1—Parkinson's disease	0.00113	0.00268	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ABL1—Parkinson's disease	0.00112	0.00268	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF2—Parkinson's disease	0.00112	0.00267	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00106	0.00254	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PLA2G6—Parkinson's disease	0.00106	0.00252	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HGF—Parkinson's disease	0.00106	0.00252	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MAOB—Parkinson's disease	0.00105	0.0025	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00104	0.00247	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000995	0.00237	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—DDC—Parkinson's disease	0.0009	0.00214	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—DDC—Parkinson's disease	0.000863	0.00206	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA4—Parkinson's disease	0.00085	0.00202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—DDC—Parkinson's disease	0.000827	0.00197	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA4—Parkinson's disease	0.000815	0.00194	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA4—Parkinson's disease	0.000781	0.00186	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2D6—Parkinson's disease	0.000779	0.00185	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLA2G6—Parkinson's disease	0.000765	0.00182	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CTGF—Parkinson's disease	0.000764	0.00182	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MAOB—Parkinson's disease	0.000758	0.0018	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PLA2G6—Parkinson's disease	0.000734	0.00175	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MAOB—Parkinson's disease	0.000726	0.00173	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2E1—Parkinson's disease	0.000712	0.0017	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—Parkinson's disease	0.000704	0.00168	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLA2G6—Parkinson's disease	0.000703	0.00168	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MAOB—Parkinson's disease	0.000696	0.00166	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TH—Parkinson's disease	0.000694	0.00165	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—Parkinson's disease	0.00068	0.00162	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYCS—Parkinson's disease	0.000666	0.00159	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—COMT—Parkinson's disease	0.00059	0.00141	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—Parkinson's disease	0.000587	0.0014	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MAOA—Parkinson's disease	0.000586	0.0014	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMOX1—Parkinson's disease	0.000579	0.00138	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2D6—Parkinson's disease	0.000563	0.00134	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—Parkinson's disease	0.000556	0.00132	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CTGF—Parkinson's disease	0.000553	0.00132	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2D6—Parkinson's disease	0.00054	0.00129	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—Parkinson's disease	0.00054	0.00129	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CTGF—Parkinson's disease	0.00053	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2D6—Parkinson's disease	0.000518	0.00123	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—Parkinson's disease	0.000517	0.00123	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2E1—Parkinson's disease	0.000515	0.00123	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—Parkinson's disease	0.000509	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CTGF—Parkinson's disease	0.000508	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TH—Parkinson's disease	0.000502	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2E1—Parkinson's disease	0.000494	0.00118	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—Parkinson's disease	0.000488	0.00116	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYCS—Parkinson's disease	0.000482	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TH—Parkinson's disease	0.000481	0.00115	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—Parkinson's disease	0.000477	0.00114	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2E1—Parkinson's disease	0.000473	0.00113	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—Parkinson's disease	0.000468	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYCS—Parkinson's disease	0.000462	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TH—Parkinson's disease	0.000461	0.0011	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOE—Parkinson's disease	0.000444	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYCS—Parkinson's disease	0.000443	0.00105	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—COMT—Parkinson's disease	0.000427	0.00102	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—Parkinson's disease	0.000425	0.00101	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MAOA—Parkinson's disease	0.000424	0.00101	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMOX1—Parkinson's disease	0.000419	0.000998	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COMT—Parkinson's disease	0.000409	0.000974	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—Parkinson's disease	0.000407	0.00097	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MAOA—Parkinson's disease	0.000406	0.000968	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—Parkinson's disease	0.000402	0.000958	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMOX1—Parkinson's disease	0.000402	0.000956	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COMT—Parkinson's disease	0.000392	0.000934	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—Parkinson's disease	0.00039	0.00093	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—Parkinson's disease	0.00039	0.00093	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MAOA—Parkinson's disease	0.000389	0.000928	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—Parkinson's disease	0.000385	0.000918	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMOX1—Parkinson's disease	0.000385	0.000917	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—INS—Parkinson's disease	0.000379	0.000904	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—Parkinson's disease	0.000374	0.000891	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—Parkinson's disease	0.000374	0.00089	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—Parkinson's disease	0.00037	0.00088	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—Parkinson's disease	0.000359	0.000854	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—Parkinson's disease	0.000358	0.000853	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—Parkinson's disease	0.000345	0.000822	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—Parkinson's disease	0.000344	0.000818	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—Parkinson's disease	0.000331	0.000788	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOE—Parkinson's disease	0.000321	0.000765	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—Parkinson's disease	0.000317	0.000755	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOE—Parkinson's disease	0.000308	0.000733	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOE—Parkinson's disease	0.000295	0.000703	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—INS—Parkinson's disease	0.000274	0.000653	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—INS—Parkinson's disease	0.000263	0.000626	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—INS—Parkinson's disease	0.000252	0.000601	CbGpPWpGaD
